[New antimicrobial agent series XXXIII: Flomoxef].
Shimizu
K
K
D000818:Animals; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy*; D002511:Cephalosporins / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D006801:Humans; D051379:Mice; D014018:Tissue Distribution
D002511:Cephalosporins; C045693:flomoxef